EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Development and Validation of an Immune-Related Prognostic Signature for Laryngeal Squamous Cell Carcinoma

Changding He, Wanqiu Peng iD, Yi Shi, Huaidong Du

Journal of Clinical Medicine · 09.07.2026 · 15 (14) · 5382

DOI: 10.3390/jcm15145382 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Clinical Medicine, online erschienen am 09.07.2026. Verfasst von Changding He und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Otorhinolaryngology, Eye & ENT Hospital, Fudan University, Shanghai 200031, China. Die Arbeit nennt 36 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Zhongshan Hospital, Shanghai Minhang District Leading Talent Project, Shanghai Pudong New Area Health Commission.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Laryngeal squamous cell carcinoma (LSCC) is a highly aggressive malignancy with poor prognosis, particularly in advanced stages. While traditional treatments have improved survival rates, reliable biomarkers for prognosis remain limited.

Methods

We analyzed RNA-seq data of LSCC patients from the Cancer Genome Atlas (TCGA) and validated the results using the Gene Expression Omnibus (GEO) dataset (GSE27020), clinical samples, and LSCC cell lines. Differentially expressed immune-related genes (DEIRGs) were identified using the “limma” R package. A prognostic signature was developed by integrating univariate Cox analysis, least absolute shrinkage and selection operator (LASSO) regression, and multivariate Cox analysis. The signature’s predictive performance was validated using Kaplan–Meier survival analysis and receiver operating characteristic (ROC) curves.

Results

A three-gene immune-related prognostic signature comprising TNFRSF4, PPARG, and PDGFA was established. In the training cohort, the model stratified patients into high- and low-risk groups with significantly different overall survival (HR = 5.81, 95% CI: 2.56–13.22, p < 0.001), with apparent 1-, 2-, and 3-year AUC values of 0.838, 0.895, and 0.947, respectively. Predictive performance was further evaluated in the TCGA testing cohort, the full TCGA cohort, and the GSE27020 cohort. Functional enrichment analysis revealed that the signature genes are involved in immune regulation and tumor progression.

Conclusions

This study identified and validated a novel three-gene immune-related prognostic signature for LSCC, offering a practical tool for individualized prognosis and personalized treatment strategies. The signature provides insights into immune-related mechanisms in LSCC, presenting potential targets for therapeutic intervention.

Schlagwörter

Stichwörter der Autor:innen

immune-related geneslaryngeal squamous cell carcinomaprecision oncologyrisk stratification

Autor:innen und Institutionen

  • Department of Otorhinolaryngology, Eye & ENT Hospital, Fudan University, Shanghai 200031, China.
  • Zhongshan Hospital, Fudan University, Shanghai 200032, China.
  • Department of Clinical Laboratory, Punan Branch of Renji Hospital, Shanghai Jiao Tong University, Shanghai 201312, China.

ORCID-Profile: Wanqiu Peng

Förderung

  • Zhongshan Hospital
  • Shanghai Minhang District Leading Talent Project
  • Shanghai Pudong New Area Health Commission
  • Science and Technology Development Fund of Pudong New District Minsheng Scientific Research (Medical and Health) Project
  • Zhongshan Hospital, Fudan University

Zitieren

APA

He, C., Peng, W., Shi, Y., & Du, H. (2026). Development and Validation of an Immune-Related Prognostic Signature for Laryngeal Squamous Cell Carcinoma. Journal of Clinical Medicine, 15(14), 5382. https://doi.org/10.3390/jcm15145382

Vancouver

He C, Peng W, Shi Y, Du H. Development and Validation of an Immune-Related Prognostic Signature for Laryngeal Squamous Cell Carcinoma. Journal of Clinical Medicine. 2026;15(14):5382. doi:10.3390/jcm15145382

BibTeX
@article{He2026,
  author = {He, Changding and Peng, Wanqiu and Shi, Yi and Du, Huaidong},
  title = {Development and Validation of an Immune-Related Prognostic Signature for Laryngeal Squamous Cell Carcinoma},
  journal = {Journal of Clinical Medicine},
  year = {2026},
  volume = {15},
  number = {14},
  pages = {5382},
  doi = {10.3390/jcm15145382}
}
Kostenlos starten →